AMBER MAHAR: Open Payments
NPI 1982203444 · SALLISAW, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,671 in 97 payments from 18 companies in 2025. Trend: 2023 $1,934 · 2024 $2,417 · 2025 $1,671
Food & beverage: $1,671
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $255 |
| ABBVIE INC. | 19 | $212 |
| Dexcom, Inc. | 1 | $164 |
| AstraZeneca Pharmaceuticals LP | 8 | $162 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $161 |
| Lilly USA, LLC | 8 | $130 |
| E.R. Squibb & Sons, L.L.C. | 6 | $120 |
| Otsuka America Pharmaceutical, Inc. | 6 | $103 |
| PFIZER INC. | 4 | $77 |
| Viatris Specialty LLC | 4 | $66 |
Products named: VRAYLAR, Dexcom G6 Transmitter, Kerendia, Wegovy, AIRSUPRA, COBENFY, Ozempic, REXULTI.
Industry payments across OK — which companies pay providers there.
